Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tuberculosis Beyond the Lungs: A Pictorial Review of Key Diagnostic Imaging Insights.

Cureus·2025

Same author

Diagnostic Performance of Articular Ultrasound Versus Magnetic Resonance Imaging in the Approach to Rotator Cuff Lesions at a Referral Hospital.

Cureus·2025

Same author

Left Innominate Artery With Anomalous Origin From the Pulmonary Trunk: A Case Report of an Unnoticed Malformation.

Cureus·2025

Same author

Chronic Cardiac Herniation: A Peculiar Diagnosis.

Cureus·2024

Same author

Left Atrial Appendage Aneurysm: A Case Report and Literature Review.

Cureus·2024

Same author

Fluorodeoxyglucose (FDG) Uptake in the Remnant Adrenal Gland Mimicking Tumor Recurrence in a Patient With Adrenocortical Carcinoma After Treatment With Mitotane.

Cureus·2024

Search research articles

Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Eosinophilic Pneumonia Induced by Daptomycin.

Juan D Ayala Torres¹, Brian Noreña¹, Alma Tatiana Suarez Poveda¹

¹Radiology, Universidad de Antioquia, Medellín, COL.

|April 1, 2024

Summary

This summary is machine-generated.

Daptomycin-induced eosinophilic pneumonia (DIEP) is a rare antibiotic complication. Early recognition and daptomycin withdrawal are key for managing this serious lung inflammation.

Keywords:

daptomycin drug-related side effects and adverse reactions eosinofilia pulmonar pulmonary eosinophilia radiology

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Experiment Videos

Last Updated: Jun 29, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Area of Science:

Pulmonology
Infectious Diseases
Pharmacology

Background:

Daptomycin is a crucial antibiotic for Gram-positive infections.
Rare adverse pulmonary reactions can occur with daptomycin therapy.
Daptomycin-induced eosinophilic pneumonia (DIEP) is a serious, albeit uncommon, complication.

Observation:

A teenage patient with nasopharyngeal cancer developed dyspnea and eosinophilia.
Symptoms emerged during daptomycin treatment for a catheter-related infection.
Radiological imaging revealed findings consistent with eosinophilic pneumonia.

Findings:

The case highlights a distinct immune response to daptomycin, causing pulmonary inflammation.
Diagnosis involves clinical presentation, lab tests (peripheral eosinophilia), and imaging.
Bronchoalveolar lavage may reveal eosinophilic infiltration.

Implications:

Clinicians must consider DIEP in patients with respiratory issues and daptomycin exposure.
Prompt daptomycin discontinuation is the primary treatment.
Corticosteroids may be necessary for severe cases of daptomycin-induced lung injury.